Clinical trial
Prevention of Aromatase Inhibitor-Induced Toxicity With Omega-3 Supplementation
NCT02831582 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Aromatase Inhibitor-Induced Toxicity With Omega-3 Supplementation
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 12, 2016
- Completion date
- December 11, 2021
- Enrollment
- 75 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.